Drug Delivery
Pediatric Drug Delivery
Technology and Product Opportunities
| Publication Date | February 2009 |
| Publisher | MCD Group |
| Product Type | Report |
| Pages | 275 |
| ISBN Number | not applicable |
| Product Code | MCD00001 |
Price
£1,715.00
approximately: $2,597 | €1,914
approximately: $2,597 | €1,914
pdf immediate delivery
print £1,860 ($2,816 | €2,076)
Order above formats by FAX
Summary
The purpose of this report is to provide relevant market and technology information related to the pediatric pharmaceutical market. This report features valuable market data and product information on pediatric-focused products. The report also features detailed company and technology information which is designed to facilitate strategic alliances within the pediatric segment.
Report Contents
- Market Analysis of US Pediatric Market
- Discussion of pediatric market size and needs
- Rx Pediatric Market Size, 2007
- Sales of 25 common drugs prescribed to pediatrics
- Sales of leading pediatric-focused products
- Sales of key products in therapeutic categories applicable to
- pediatrics (ADHD, Antibiotics, Allergies, etc.)
- Drug Delivery Systems for Pediatrics
- Marketed Products
- DDS products approved for pediatric use
- OTC DDS products approved for pediatrics
- Dosage Forms and Technologies
- Taste masking, orally disintegrating dosage forms, soft chewable delivery systems, oral liquids, oral mucosal systems, transdermal and topical systems, nasal and pulmonary delivery, parenteral and device technologies
- Pediatric pipeline products by formulation type
- Formulation Opportunities in the Pediatric Segment
- Oral reformulation
- Taste masking
- Dosage form changes
- Profiles of Specialty Pharma Companies with Pediatric Focus
- 20+ company profiles including Arbor Pharmaceuticals, Centrix
- Pharmaceutical, Madeira Therapeutics, Next Wave
- Pharmaceuticals, and Pediapharm Inc.
- Profiles of DDS Technologies Applicable to Pediatric Medicine
- 60+ technology profiles
- Pediatric Product Licensing Opportunities
- 30+ licensing opportunities including:
- Decongestant patch
- Non-insecticidal lice treatment
- Novel teething gel
- ODT analgesic
- 30+ licensing opportunities including:
Contents
- 1. Executive Summary
- Market Overview
- Drug Delivery Systems for Pediatrics
- Overview of Delivery Systems Profiled
- Formulation Opportunities
- Specialty Pediatric Companies
- Product Licensing Opportunities
- 2. Pediatric Market Overview
- Market Needs
- Therapeutic Needs
- Hypertension
- Hypercholesterolemia
- Diabetes
- Pain Management
- Anti-Infectives
- Respiratory / Allergy
- Attention Deficit Hyperactivity Disorder
- Epilepsy
- Market Size
- Figure 1: US Prescription Pediatric Market, 2007
- Key Therapeutic Areas
- CNS
- Allergies
- Asthma
- Infections
- Key Therapeutic Areas
- 3. Drug Delivery Systems for Pediatrics
- Marketed Products
- Dosage Forms
- Taste Masking
- Orally Disintegrating Dosage Forms
- Soft Chewable Delivery Systems
- Oral Liquid Delivery Systems
- Oral Mucosal Delivery Systems
- Transdermal Delivery Systems
- Topical Delivery Systems
- Nasal Drug Delivery
- Pulmonary Delivery Systems
- Parenteral and Device Technologies
- 4. Formulation Opportunities
- Oral Reformulation
- Taste Masking
- Non-invasive Formulations
- 5. Companies with Pediatric Marketing Focus
- Adams Respiratory Therapeutics LLC
- Arbor Pharmaceuticals, Inc
- Asklepion Pharmaceuticals, Inc
- Centrix Pharmaceutical, Inc
- Cornerstone Therapeutics, Inc
- Dexo LLC
- InfaCare Pharmaceutical Corporation
- Lupin Pharmaceuticals, Inc
- Madeira Therapeutics
- McNeil Pediatrics
- Meritage Pharma, Inc
- Next Wave Pharmaceuticals, Inc
- Norgenix Pharmaceuticals, Inc
- ParaPRO LLC
- Pediapharm, Inc
- Sciele Pharma, Inc
- TaroPharma
- Teva Specialty Pharmaceuticals LLC
- Tiber Laboratories, LLC
- Topaz Pharmaceuticals Inc
- TRx Pharma
- 6. Drug Delivery Technologies for Pediatric Drugs
- Buccal Delivery Systems
- APTYS Pharmaceuticals
- Biodel Inc
- BioDelivery Sciences International
- Columbia Laboratories, Inc
- Corium International, Inc
- Fertin Pharma
- NovaDel Pharma
- Orexo AB
- ULURU, Inc
- Watson, Inc
- Oral Delivery Systems
- Akina, Inc
- ARx, LLC
- Alpex Pharma SA
- Antares Pharma
- Banner Pharmacaps
- Biovail Corporation
- Capricorn Pharma, Inc
- Capsulution Pharma AG
- Catalent Pharma Solutions
- CIMA Labs, Inc
- Collegium Pharmaceutical Inc
- Dow Wolff Cellulosics
- Elan Drug Delivery
- Egalet A/S
- Ethypharm
- Eurand, Inc
- ForTe BV
- Grunenthal GmbH
- HealthSport, Inc
- IntelGenx Corporation
- KV Pharmaceutical Company
- Labtec Pharma
- Lavipharm
- Losan Pharma GmbH
- LTS Lohmann
- Meldex International
- MonosolRx
- Oral Delivery Technologies, LLC
- Physica Pharma
- SPI Pharma Inc
- Tris Pharma
- Taste Masking Technologies
- APIcross Drug Delivery Technologies
- Balchem Corporation
- Cambrex Corporation
- Ethypharm
- Eurand, Inc
- ForTe BV
- Oralance Pharma
- Redpoint Bio Corporation
- Nasal Technologies
- DelSite Biotechnologies, Inc
- Kurve Technology, Inc
- Intranasal Therapeutics, Inc
- OptiNose
- Dermal Delivery Technologies
- Altea Therapeutics
- Crospon Ltd
- Foamix Ltd
- ForTe BV
- Intercell
- nanoBioSciences, LLC
- Pantec Biosolutions
- TransPharma Medical
- Zosano Pharma
- Buccal Delivery Systems
- 7. Product Licensing Opportunities
- Albuterol Dry Powder Inhaler
- Allergy Chewing Gum
- AllerNaseTM Nasal Spray
- Atopic Dermatitis Treatment
- AtopiclairTM Cream
- CRO-PED for Pediatric Diarrhea
- Children's Dietary Supplement
- Ciprofloxacin Otic Solution
- Decongestant Cream Stick
- Decongestant Patch
- Fever Cooling Patch
- Foam-Based Dermatology Products
- Foam-Based Products for Infants
- GastroGard-R for Rotavirus
- HedrinTM for the Treatment of Head Lice
- Human Growth Hormone Nasal Spray
- Insect Repellent Patch
- Insecticide-Free Head Lice Treatment
- Lidocaine Powder Injection System
- Liposomal Amikacin Formulation
- Long-acting Somatropin Injection
- Moisturizing Cream for Dermatitis
- Nasal Somatropin Formulation
- NeoCeramTM Skin Barrier Emulsion
- Non-Pesticidal Product for Head Lice
- Novel Head Lice Formulation
- Once-weekly Injectable Somatropin
- Oral Film Formulation of Prednisolone
- Oral Rotavirus Thin Film Product
- Orally Disintegrating Acetaminophen Formulations
- Peptide for Chronic Middle Ear Infections
- Sinlice, Pediculicide Treatment
- Site-Specific Otitis Media Treatment
- Sustained Release Somatropin Injection
- Teething Gel for Babies
- Zinc Oxide Spray
- INDEX OF TABLES
- Table 1: Pediatric Age Related Sub Groups
- Table 2: Antihypertensives Granted Pediatric Exclusivity
- Table 3: Cholesterol Drugs Granted Pediatric Exclusivity
- Table 4: Diabetes Products Used in Pediatrics
- Table 5: Pain Medications Granted Pediatric Exclusivity
- Table 6: Emerging Technologies for Antibiotics
- Table 7: Leading Respiratory/Allergy Products for Pediatrics
- Table 8: ADHD Medications for Pediatrics
- Table 9: Drugs Approved for Epilepsy
- Table 10: Sales of 25 Drugs Commonly Prescribed to Pediatrics
- Table 11: Sales of Leading Pediatric-Focused Products, 2007
- Table 12: Sales of Leading ADHD Drugs, 2007
- Table 13: Sales of Leading Allergy Drugs, 2007
- Table 14: Sales of Leading Asthma Drugs, 2007
- Table 15: Pediatric Oral Antibiotic Market
- Table 16: DDS Products Approved for Pediatric Use
- Table 17: OTC DDS Products for Pediatrics
- Table 18: Key Players in Taste Masking
- Table 19: ODT Technology Summary
- Table 20: Key Players in ODT Market
- Table 21: Oral Film Technology Summary
- Table 22: Key Players in Oral Film Market
- Table 23: ODD Pipeline Products for Pediatrics
- Table 24: Advantages of Chewable Dosage Forms
- Table 25: Soft Chewable Delivery Systems
- Table 26: Liquid Drug Delivery Technologies
- Table 27: Liquid Pediatric Products in Development
- Table 28: Key Players in Buccal Delivery
- Table 29: Transdermal Pediatric Products
- Table 30: Transdermal Pipeline for Pediatrics
- Table 31: Topical Pediatric Pipeline
- Table 32: Nasal Pipeline Products Applicable to Pediatrics
- Table 33: Pulmonary Pipeline for Pediatrics
- Table 34: Parenteral DDS Pediatric Pipeline
- Table 35: Pediatric Drug Candidates for Oral Reformulation
- Table 36: Taste Masking Development Opportunities
- Table 37: Non-invasive Reformulation Opportunities
- Table 38: Marketed Products by ART
- Table 39: Arbor Product Pipeline
- Table 40: Asklepion Pipeline
- Table 41: Marketed Products of Centrix
- Table 42: Therapeutic Target of Centrix
- Table 43: Cornerstone Products Prescribed to Pediatrics
- Table 44: Dexo's Current & Past Marketed Products
- Table 45: Dexo Pipeline Products
- Table 46: Madeira Product Pipeline
- Table 47: McNeil's Pediatric Product Developments
- Table 48: Marketed Products by Next Wave
- Table 49: Pediapharm Pipeline
- Table 50: Pediatric Products Marketed by Sciele
- Table 51: Sciele Pediatric Pipeline
- Table 52: NonSpil OTC Products
- Table53: Rx Products Marketed by Taro
- Table 54: Teva's Key Products for Pediatrics
- Table 55: Pediatric Products Marketed by Tiber
- Table 56: Viadel Pipeline
- Table 57: Columbia Pipeline Products
- Table 58: NovaDel Pipeline
- Table 59: Orexo's Sublingual Pipeline
- Table 60: Alpex Pipeline
- Table 61: Marketed Zydis Products
- Table 62: Catalent Product Pipeline
- Table 63: Products Developed by CIMA
- Table 64: Ethypharm's ODT Products
- Table 65: Eurand's ODT Products
- Table 66: Healthsport Products
- Table 67: LTS Wafer Systems
- Table 68: Meldex DDS Pipeline
- Table 69: MonosolRx Pipeline
- Table 70: Products Containing Microcaps Technology
- Table 71: NODSPipeline
- Table 72: OptiNose Pipeline
- Table 73: ViaDerm Pipeline
